Sign in
CFRX Stock Price, Chart, Stats & News
ContraFect Corporation
Save
–
Market cap
–
Current P/E
–
Forward P/E
CFRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -315.07% |
ROE | -347.26% |
D/E | -0.24x |
Interest coverage ratio | -104.38x |
CFRX valuation
P/E | – |
P/S | – |
P/B | -0.00x |
P/CF | -0.00x |
P/FCF | – |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.09x |
About
ContraFect Corporation is a biotechnology firm operating at the clinical stage, dedicated to the discovery and development of innovative therapeutic proteins and antibodies. Its primary mission is to address life-threatening and drug-resistant infectious diseases within the United States. The company's most advanced candidate, Exebacase, a specialized enzyme known as a lysin, is currently undergoing Phase III clinical trials.
Similar securities
Based on sector and market capitalization
Report issue